Drug: infliximab, recombinant Quarter: 2016Q3
Total Drug/Injury Combinations: 276 Number of Pages: 14
| DRUGNAME | PT | EventCount | |
|---|---|---|---|
| INFLIXIMAB, RECOMBINANT | Lung neoplasm malignant | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Malaise | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Malnutrition | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Megacolon | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Melaena | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Metastases to central nervous system | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Metastasis | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Myocardial infarction | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Non-Hodgkin's lymphoma | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Pancreatitis | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Pancreatitis acute | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Plasma cell myeloma | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Pneumocystis jirovecii pneumonia | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Prostatic specific antigen increased | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Retinal melanoma | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Skin disorder | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Small intestine carcinoma recurrent | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Stoma closure | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Subcutaneous abscess | 2 | view events |
| INFLIXIMAB, RECOMBINANT | Superficial spreading melanoma stage unspecified | 2 | view events |
Total Drug/Injury Combinations: 276 Number of Pages: 14
NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)